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 Chromatin remodeling accompanies differentiation, however, its role in self-renewal is less-well 
understood. We report that in Drosophila the chromatin remodeler Kismet/CHD7/CHD8 limits intestinal 
stem cells (ISC) number and proliferation without affecting differentiation. Stem cell-specific whole-
genome profiling of Kismet revealed its enrichment at transcriptionally active regions bound by RNA 
Polymerase II and Brahma, its recruitment to transcription start site of activated genes and developmental 
enhancers and its depletion from regions bound by Polycomb, Histone H1 and heterochromatin Protein 1. 
We demonstrate that the Trithorax-related/MLL3/4 chromatin modifier regulates ISC proliferation, 
colocalizes extensively with Kismet throughout ISC genome, and co-regulates genes in ISCs, including Cbl 
a negative regulator of Epidermal Growth Factor Receptor (EGFR). Loss of kismet or trr leads to elevated 
levels of EGFR protein and signaling, thereby promoting ISC self-renewal. We propose that Kismet with 
Trr establishes a chromatin state that limits EGFR proliferative signaling, preventing tumor-like stem cell 
overgrowths. 
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 Regulation of stem cell proliferation rates is critical in adult tissues, which need to maintain basal 
renewal as well undergo damage-induced regenerative responses. Consequently, the dysregulation of stem cell 
proliferation can have pathological effects. Ample evidence now supports a functional link between the 
deregulated proliferation of stem cells and cancer initiation as well as metastatic progression (de Sousa E Melo 
et al., 2017; Flavahan et al., 2017). Interestingly, the loss of epigenetic control is a major contributor to stem 
cell misregulation including proliferation deregulation during aging (Brunet and Rando, 2017; Challen et al., 
2014; Ko et al., 2011). Therefore, in addition to roles of epigenetic regulation during differentiation of stem 
cell-derived lineages, chromatin modulation also has important, though not yet well understood, roles in 
control of stem cell proliferation. 
 A useful model to investigate adult stem cell regulation is the Drosophila midgut, which is maintained 
by around 1000 multipotent ISCs. Most ISC divisions lead to asymmetric daughter cell fates resulting in a self-
renewed ISC and a sister enteroblast (EB) cell (Figure 1A). A majority of EBs receive high levels of Notch 
signaling and differentiate into enterocyte cells (ECs). Rare stem cell divisions produce an Enteroendocrine 
Precursor cell (EEPs) with low or no Notch signaling, which is thought to divide once to make two 
enteroendocrine cells (EEs) (Chen et al., 2018; Ohlstein and Spradling, 2007; Sallé et al., 2017). In response 
to epithelial damage, several signaling pathways become activated and coordinate ISC proliferation and 
differentiation (see for review: (Jiang et al., 2016)). Of primary importance are signals that the ISCs receive to 
activate the Jak/Stat and EGFR pathways (Biteau and Jasper, 2011; Buchon et al., 2010; 2009; Jiang et al., 
2011; 2009; Wang et al., 2014; Xu et al., 2011). Moreover, other pathways such as Insulin, Hippo, Jun Kinase, 
BMP, Wnt, and Hedgehog also control ISC proliferation (Biteau et al., 2008; Cordero et al., 2012; Li et al., 
2013; 2014; Lin et al., 2008; O'Brien et al., 2011; Ren et al., 2010; Shaw et al., 2010; Staley and Irvine, 2010; 
Tian and Jiang, 2014; Tian et al., 2015; 2017). Evidence suggests that there are also mechanisms to limit ISC 
responsiveness, tuning down cell division when sufficient renewal has occurred (Guo et al., 2013; Hochmuth 
et al., 2011), though this process is not well understood. 
 Here we report on the identification of a regulator that is essential to limit ISC proliferation: kismet, 
similar to the chromodomain containing chromatin remodeling factors CHD7 and CHD8. Mammalian CHD7 
is associated with transcriptionally active genes at enhancers, superenhancers, and promoters where it can both 
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activate and repress transcription (Hnisz et al., 2013; Schnetz et al., 2009; 2010). kismet was originally 
identified as a “trithorax group” gene because of its ability to dominantly suppress Polycomb mutant 
phenotypes (Kennison and Tamkun, 1988). Studies using the polytene chromosomes of the salivary gland have 
shown that Kismet is associated with transcriptionally active chromatin, where it recruits the histone methyl 
transferases Trithorax and Ash1. Ash1 recruitment, in turn, is thought to promote H3K36me2, leading to 
inhibition of Histone H3K27me3 (Dorighi and Tamkun, 2013). In addition, as kismet mutants show a reduction 
in elongating RNA Pol II, Kismet was proposed to promote transcription elongation (Srinivasan et al., 2008). 
Whether Kismet acts in other tissues via similar molecular effectors is not currently known. 
 CHD7/CHD8 and Kismet have essential functions during development and in adult tissues. In humans, 
inactivation of CHD7 causes CHARGE syndrome, a spectrum of congenital defects (Bajpai et al., 2010; 
Vissers et al., 2004). Moreover, CHD7 is essential for neural development, for adult neural stem cell 
maintenance and is deregulated in cancers (Feng et al., 2013; 2017; Jones et al., 2015; Pleasance et al., 2010; 
Robinson et al., 2012). CHD8 mutations are associated with neurodevelopmental defects in autism spectrum 
disorders (Neale et al., 2012; O’Roak et al., 2012; Talkowski et al., 2012). In Drosophila, kismet mutants have 
defects in developmental patterning with homeotic transformations as well as alteration of circadian rhythm 
and memory (Daubresse et al., 1999; Dubruille et al., 2009; Melicharek et al., 2010; Terriente-Félix et al., 
2010; 2011). However, to date, functions of kismet in stem cells have not been described. 
 Here we demonstrate that Kismet is an important regulator of ISCs, essential to limit basal levels of 
ISC proliferation. DamID-Seq of Kismet compared with DamID reporters of different chromatin states, 
including activated (Brahma, RNA pol II) and repressed states (Polycomb, Histone H1, Heterochromatin 
Protein 1 [HP1]) demonstrated that Kismet preferentially localized to transcriptionally active regions of the 
genome and to developmental enhancers. In addition, our data suggest that Kismet acts in ISCs with the H3K4 
monomethyltransferase, Trithorax-related Complex (Trr, mammalian MLL3/4). We find that Trr and Kismet 
co-localize in the genome and co-regulate the transcription of many genes, including Cbl, a negative regulator 
of EGFR signaling. Our data therefore demonstrate that the chromatin regulators Kismet/CHD7/CHD8 and 
Trr-Complex/MLL3/4 function together to limit basal levels of ISC proliferation and identify Cbl as a key 




Identification of kismet as an essential gene controlling stem cell homeostasis 
 We screened for EMS induced mutations affecting ISC activity and intestinal homeostasis (C.P., F.S. 
and A.B., unpublished) and found one line (10D26) that showed an increase in the size of mutant clones 
generated in the midgut of adult flies (Figure 1B, C) and had a higher proportion of cells expressing Delta, an 
ISC marker (8.9 Delta+ cells, 44% of clone) when compared to the control (1.6 Delta+ cells, 20% of clone; 
Figure 1D). In addition, these cells expressed  the ISC marker Sanpodo (Perdigoto et al., 2011) (Figure S1A-
B). Therefore, 10D26 mutant clones induce aberrant accumulation of stem cells (Figure 1E). 
 Deficiency mapping followed by failure to complement three known alleles of the kismet gene 
(kismet1, kismetEC1 and kismetLM27), indicated that 10D26 harbored a lethal mutation in kismet. kismet encodes 
a conserved chromatin remodeling factor, similar to CHD7 and CHD8 in mammals. kismet encodes a long 
(Kismet-L) and short (Kismet-S) isoform, with only Kismet-L containing two chromodomains and a SNF2-
like ATPase/helicase domain, required for nucleosome remodeling activity (Bouazoune and Kingston, 2012) 
(Figure 1F). All four alleles correspond to nonsense mutations early in kismet-L coding sequence (Figure 1F). 
Clones for kismetEC1, and kismetLM27, kismet1 reproduced kismet10D26 phenotypes (Figure S1C, D, O, Q, S, U and 
V). No phenotype was observed outside of clones, arguing against dominant-negative action of truncated 
proteins (Figure 1C and Figure S1D, O, Q, S). kismet10D26 phenotypes were rescued by a transgenic BAC 
construct (kislocus) encompassing the genomic locus containing kismet fused to a FLAP tag-encoding sequence 
(Star Methods; Figure S1C-F). In addition, the expression of kismet-L cDNA, rescued clone size and increased 
stem cell number phenotypes of kismet10D26, kismetEC1, kismetLM27, and kismet1 alleles (Figure S1G, H, M-V). 
In contrast, kismet-S cDNA expression did not rescue kismet10D26 phenotypes (Figure S1I, J, M and N). 
Therefore, we conclude that kismet-L is required for normal midgut homeostasis. We will henceforth refer to 
kismet-L as “kismet”. Interestingly, the overexpression of an ATPase-dead version (KismetK2060R) also showed 
a partial rescue of the mutant phenotype (Figure S1K-N). These data suggest that additional functional domains 
of Kismet are important for stem cell regulation, possibly by bridging interactions with other factors. 
 We then asked whether terminal differentiation was affected by the loss of kismet. kismet mutant 
clones, like wild-type clones were able to produce terminally differentiated EC (Pdm1) and EE cells (Pros), 
though made more per clone, consistent with larger clone sizes (Figure 1G-P). Additional markers for 
differentiated EEs (peptide hormones DH31 and LTK2) and ECs (apical brush border) were detected in kismet 
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mutants (Figure 1G-J’, Q, R). Thus, we conclude that loss of kismet function in ISCs results in increased stem 
cell numbers, without major defects in terminal differentiation. 
 
Kismet activity limits proliferation and self-renewal of the ISC 
 We then hypothesized that an increase in ISC numbers could be due to altered proliferation. 
Consistent with this, at 30 days AHS kismet mutant tissue took over most of the midgut (Figure 2A, B) 
suggesting that mutant clones have a growth advantage over both heterozygous and wild-type cells. 
Since ISCs are the primary dividing cell type in the midgut, we then assessed ISC proliferation 
using phospho-Histone H3 (PH3) as a marker for mitotic cells. 7.6% of the control clones had at least one 
and never more than one mitotic cell per clone (Figure 2C-E’). In contrast, 21.4% of kismet mutant clones 
had at least one mitotic cell and clones with more than one dividing cell were detected (Figure 2C, D, F, 
F’). We assessed cell cycle parameters using the Fly-FUCCI system (Zielke et al., 2014) and found that 
kismet mutants had increased proportion of ISCs in S phase and G2/early M at the expense of the G1 fraction 
(Figure 2G-I). Altogether, these data further support the idea that kismet mutant ISCs have deregulated 
proliferation. 
  
Kismet controls cell division in a stem cell-autonomous manner 
 To determine in which cell kismet activity is required, we first assessed its expression profile in the 
intestine. An antibody recognizing the C-terminal part shared by the short and long forms of Kismet, showed 
enrichment in cells positive for Escargot (esg), a marker of ISCs and EBs, and in EE cells compared to ECs 
(Figure 2J-K’). To test cell type-specific requirements of kismet, we verified that expressing kismet RNAi 
constructs mimicked kismet mutant phenotypes and led to the loss of Kismet protein (Figure 2L-N and Figure 
S2A-E’). ISC-specific or ISC and EB simultaneous knock-down of kismet led to an accumulation of ISCs and 
increased proliferation (Figure 2O-R and Figure S2F, G). However, kismet knock-down in EEs, ECs or in EB 
cells only, did not show ISC phenotypes (Figure 2R and Figure S2H-M). We conclude that kismet activity is 
required in ISCs to limit their proliferation to a basal level and to prevent abnormal expansion of their pool. 
 
Kismet mutant cells activate Notch signaling and can differentiate upon forced Notch activation 
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We next explored a potential impact of kismet on the Notch signalling pathway, which limits stem cell 
numbers by controlling daughter cell fate decisions (Bardin et al., 2010; Micchelli and Perrimon, 2006; 
Ohlstein and Spradling, 2006). We reasoned that, as a regulator of transcription, Kismet might be necessary 
for expression of Notch. This was not the case, and Notch expressing cells were in fact more abundant due to 
the accumulation of ISCs (Figure S3A, B). Furthermore, a reporter for the Notch pathway (NRE-lacZ; Notch 
Responsive Element), which is restricted to the EC-committed EB cells in wild-type tissue, was still expressed 
in kismet mutant clones, though absent from the extra Delta+ cells (Figure S3C-F). 
We further examined whether kismet mutants might block Notch target gene activation. To test this, 
we induced kismet mutant clones and allowed 10 days of growth to accumulate extra ISCs (Figure S3G). We 
then induced expression of an active form of Notch in the mutant cells (NAct) by shifting to 29°C to inactivate 
a temperature sensitive GAL80 (GAL80ts). At 18°C, control guts showed isolated Delta+ ISCs, whereas those 
with induced kismet mutant clones showed clusters of Delta+ ISCs (Figure S3H, I). However, expression of 
NAct in kismet mutant clones that had accumulated ISCs, caused differentiation of ISCs into ECs (Figure S3J, 
K, L). Therefore, we conclude that kismet inactivation leads to the accumulation of extra-ISCs that maintain 
their potential to differentiate and activate Notch, though alteration in the kinetics of Notch signalling 
activation could not be excluded. 
 
Kismet is required to maintain a basal level of activation of EGFR signaling 
As EGFR signaling is one of the primary signaling pathways controlling ISC proliferation (Biteau and 
Jasper, 2011; Buchon et al., 2010; Jiang et al., 2011). We then investigated whether kismet mutant stem cells 
may have increased EGFR signaling. In wild-type clones at 10 days AHS, a marker for activation of the EGFR 
pathway, dpERK, was weak in ISCs and mostly absent in other clonal cells (Figure 3A, A’). In kismet mutant 
clones, dpERK was strongly induced in ISCs and other cells of the clone (Figure 3B, B’). In addition, a reporter 
of cyclin E, acting downstream of EGFR signaling to regulate proliferation, was more highly induced in kismet 
mutant clones compared to wild-type at 9 days AHS and as early as 3 days AHS (Figure 3C-G). Consistent 
with a rapid activation of EGFR signaling in kismet mutants, an increased proportion of ISCs with dpERK 
signaling was detected as early as 3 days after kismet RNAi induction in ISCs (Figure 3H-J). Furthermore, the 
abnormal self-renewal of ISCs induced by loss of kismet was abolished upon blocking EGFR signaling using 
a dominant negative form of EGFR (EGFRDN) or expression of capicua (cic), a downstream repressor of EGFR 
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target genes (Figure 3K-R). Not only was kismet mutant clone size reduced when EGFR signaling was 
downregulated, but there was also a reduction in the percent of ISCs per clone, returning to wild-type (Figure 
3O, R). This suggests that ectopic activation of EGFR signaling in kismet mutant clones drives extra cell 
division and promotes the accumulation of stem cells. 
Previous work has shown that additional stress signaling pathways can further stimulate ISC 
proliferation due to feedback on EGFR signaling (Patel et al., 2015). In addition to EGFR signaling, Jun kinase 
signaling (assayed by puc-LacZ) and Jak/Stat signaling (assayed by 10XSTAT GFP) were also activated in 
ISC of 9 days kismet mutant clones (Figure S4A-D’). The genetic inactivation of Yki, Stat, Insulin, and Jun 
kinase also reduced ISC proportion in kismet mutants (Figure S4E). In order to determine whether these 
pathways may also act early with EGFR signaling in kismet mutant stem cells to drive ISC proliferation, we 
examined a 3 days timepoint after clone induction. We did not detect early activation of the Jak/Stat ligands, 
Upd-LacZ, or the Jun Kinase reporter puc-LacZ in ISCs or Upd3-LacZ in ECs (Figure S4F-N). Since kismet 
is required in the ISC autonomously, an absence of early activity of these pathways in the ISC argues against 
abnormal activation being the earliest defect in kismet mutant responsible for ISC proliferation. Therefore, our 
data suggest that an initial enhancement of EGFR signaling occurs, followed by activation of additional 
pathways during the following 10 days of clone growth and further driving mutant clone growth. We conclude 
that Kismet is required to limit EGFR signaling in ISCs. 
 
Kismet localizes to chromatin enriched in RNA pol II and Brahma and depleted for HP1, Histone H1 and 
Polycomb 
 To further understand how Kismet regulates ISC self-renewal, we identified Kismet-bound regions of 
the ISC genome using a targeted DamID-Seq strategy (Star Methods) (Marshall et al., 2016). A Dam-Kismet 
(Dam-Kis) fusion protein construct was expressed in ISCs using esgts, NRE-GAL80 for 1 day and significantly 
methylated GATC sites as compared to Dam-alone control expression were determined. Kismet distribution 
revealed enrichment in introns and 5’ UTR (Figure 4A). We identified 3032 genes containing Kismet peaks, 
defined by two, consecutive significant GATC sites (p<0.01), (Table S1). 
 To gain further insight into the type of chromatin bound by Kismet, we took advantage of DamID lines 
mapping different active and inactive chromatin states. Active regions are rich in RNA Pol II and Brahma 
whereas inactive states are enriched in Polycomb (a reader of Histone H3K27me3), Histone H1, or 
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Heterochromatin Protein 1 [HP1, a reader of Histone H3K9me3] (Marshall and Brand, 2017). Global patterns 
of Histone H1, HP1 and Polycomb binding were consistent with localization to repressed regions of the 
genome, whereas Brahma and RNA pol II along with Kismet were enriched in active genic regions (Figure 
4B, L). Histone H1 and HP1 were largely excluded from genic regions with HP1 strongly enriched at 
centromere proximal regions of the genome and the 4th chromosome, which is largely heterochromatic in flies 
(Figure S5H, Figure 4B). These data are fully consistent with data from the nervous system (Marshall and 
Brand, 2017). We then examined global distribution of Kismet relative to RNA Pol II, Brahma, Polycomb, 
Histone H1 and HP1 using Uniform Manifold Approximation and Projection for Dimension Reduction 
(UMAP; Figure 4C (McInnes et al., 2018)). This approach allows the visualization and separation in a two-
dimensional space, similar to a t-SNE plot, of GATC sites based on methylation levels by each of these factors 
(Figure 4C, GATC density map). Globally, Kismet had little overlap on UMAP with Histone H1 and HP1 
(Figure 4C) or with genes containing peaks of Histone H1 and HP1 (2.5% and 11.3%, respectively Figure 4D, 
Table S2). A majority of Kismet-rich GATC sites did not have strong Polycomb enrichment (Figure 4C, Table 
S2) and 14.5% of genes with Kismet peaks also had peaks of Polycomb (Figure 4E). Consistent with this, 
super-resolution imaging in polyploid EC cells, which allow better spatial resolution than ISCs, showed that 
Kismet and Histone H3K27me3 poorly colocalized (Figure S5A-A”).  Therefore, we conclude that Kismet 
does not substantially localize to repressed chromatin domains. 
 Our data suggested, however, that Kismet more strongly overlapped with activated chromatin states, 
visualized on UMAP by Kismet enrichment with RNA pol II and also to some extent with Brahma, a SWI/SNF 
chromatin remodeling factor associated with Histone H3K27ac (Figure 4C). 85.1% of genes with peaks for 
Kismet also had peaks for RNA pol II and 33.0% had a peak for Brahma (Figure 4F, G, Table S2). Altogether 
these data suggest that Kismet localizes to transcriptionally active regions of the genome while being depleted 
in repressed chromatin. 
 
Kismet localizes to transcriptionally active genomic regions and developmental enhancers 
 We then assessed how Kismet localized relative to active genes and enhancers. We established a list 
of expressed or “active” ISC genes based on Dam-RNA Pol II gene occupancy, a good proxy for gene 
expression (Marshall and Brand, 2015; Southall et al., 2013) (Star Methods). 4539 genes had significant 
occupancy suggesting that they are expressed, including many known ISC enriched genes (esg, sox21a, Delta, 
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spdo; Table S3). Accordingly, this genes strongly overlap with published RNAseq data for ISC express genes 
(Dutta et al., 2015) (Figure 4H). We found that 67.0% of the genes with Kismet peaks were also occupied by 
RNA pol II (Figure 4I). Genes enriched for Kismet and RNA pol II, or enriched for one but not the other were 
also detected (examples in Figure S5B-H). Separately analyzing ISC genes that were active (Dam-RNA Pol II 
occupied) or silent (Dam-RNA Pol II not occupied) revealed that Kismet, like its mammalian homologues 
CHD7/CHD8, was preferentially enriched around the Transcription Start Sites (TSS) of active genes (Figure 
4J) (Schnetz et al., 2009; 2010). 
 Interestingly, while Kismet showed a strong enrichment for genes active (Figure 4J), it was also 
associated with a subset of silent genes in ISCs that are expressed in differentiated EE (Pros) and EC cells 
(Pdm1): 163 of 569 EE+ EC specifically enriched genes had Kismet peaks (from published RNAseq (Dutta et 
al., 2015) see Star Methods; examples in Figure S5C, D). Thus, while we detected no obvious roles in terminal 
differentiation, Kismet appeared to mark a subset of genes in ISCs that will be expressed during differentiation. 
We then investigated the binding profiles of Kismet and RNA pol II at previously published enhancers 
defined in S2 cells as being either “developmental” or “housekeeping” (Zabidi et al., 2015). Interestingly, 
Kismet showed enrichment over developmental enhancers, whereas RNA pol II was enriched over both types 
of enhancers (Figure 4K). Thus, we conclude that Kismet is broadly distributed on many active genes in ISCs 
and is enriched at developmental enhancers. 
 
Knock-down of the components of the Trr COMPASS-like complex mimic kismet mutant phenotypes 
Kismet has previously been shown to restrict Histone H3K27me3 marks in the salivary gland (Dorighi 
and Tamkun, 2013; Srinivasan et al., 2008; 2005). Therefore, we examined whether kismet inactivation in the 
gut had a similar effect on limiting Histone H3K27me3 but found no detectable global increase in H3K27me3 
in kismet mutants (Figure S6A-B’). Previous studies have shown that Kismet acts in the salivary gland cells 
via recruitment of the histone methyltransferases Ash1 and Trx (Dorighi and Tamkun, 2013). Arguing against 
this possibility, we found that neither ash1 nor trx clonal loss led to deregulation of ISC proliferation (Figure 
S6C-E, H, I). Similarly, Brahma has been shown to co-localize with Kismet and share similar functions in 
transcription elongation (Armstrong et al., 2002; Srinivasan et al., 2005). However consistent with previously 
published data in the intestine, brahma RNAi expressing clones were smaller and had less ISC per clone than 
 11 
controls (Figure S6F, H, I) (Jin et al., 2013). Therefore, our data suggest that Kismet mediates its action on 
ISC proliferation through direct or indirect interaction with additional chromatin regulators. 
We reasoned that additional Trithorax-Group genes might function with Kismet and sought to identify 
these factors. To this end, we tested the effect of the histone methyl transferases-encoding genes (Mohan et 
al., 2011): dSet1 (Set1A/Set1B in mammals), and Trithorax-related (Trr; MLL3/MLL4 in mammals). The 
clonal expression of a previously validated RNAi construct against set1 (Herz et al., 2012) had no obvious 
effects on ISCs or clone size (Figure S6G). However, knockdown of genes encoding Trr-Complex proteins 
(Trr, Lost polyhomeotic domains of Trr [Lpt], and the histone demethylase Utx) revealed phenotypes similar 
to kismet (Figure 5A-F). They had an increased number of cells per clone and Delta+ cells per clone (Figure 
5A, B, E, F). Clones of the trrB mutant allele showed less severe but significant accumulation of extra-Delta+ 
diploid ISCs (Figure S6J-L’). Furthermore, the knock-down of lpt and Utx, also exhibited kismet mutant-like 
phenotypes (Figure 5C-F). Analysis of Trr, Lpt, and Utx showed ubiquitous expression in the cell types of the 
midgut (Figure 5G-J’). Utx, however, was enriched in the ISC/EB (esg+) progenitor cells and EEs similar to 
Kismet localization (Figure 5G-H), and Lpt was enriched in EEs (Figure 5I, I’). The phenotypic similarity 
between kismet alleles and knockdown of trr-complex genes suggests they may collaborate to regulate ISC 
function. This idea is further supported by our findings that Kismet is enriched at developmental enhancers 
and that the Trr/MLL3/4-Complexes have well-described functions in activating enhancers (Dorighi et al., 
2017; Herz et al., 2012; Hu et al., 2013; Lee et al., 2013). Thus, we hypothesize that Kismet regulates ISC 
proliferation in conjunction with the Trr-Complex. 
 
Genome-wide co-occupancy of Kismet and Trr and co-regulation of genes 
 A prediction of collaboration between Kismet and Trr-Complex is that they may co-bind and co-
regulate genes. We found that the distribution of Kismet on polytene chromosomes largely overlapped with 
Trr (Figure 6A-B”) and in ISCs using targeted DamID-Seq of Trr (Figure 6C). Like Kismet, Trr was enriched 
over the TSS of active genes as compared to inactive genes (based on RNA Pol II occupancy; Figure 6D). 
Interestingly, while Kismet had preferential enrichment for developmental enhancers (Figure 4K), Trr was 
equally enriched at both developmental and housekeeping enhancers (Figure 6E). Examining peaks in genes, 
73.2% of Kismet-bound genes were co-bound by Trr (Figure 6F, Table S4). We conclude that Kismet and Trr 
share genome-wide localization and binding to the genes, supporting our hypothesis that they act in concert. 
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 We then wanted to assess whether similar genes might be deregulated upon kismet or trr knockdown. 
To this end, we FACS sorted adult ISCs (esgts>GFP, NRE-GAL80) of controls (white RNAi) or those 
expressing RNAi against kismet or trr and performed RNAseq (Figure 6G-I, Table S5). Interestingly, 50.3% 
of genes having altered RNA upon kismet knockdown and 43.8% of genes having altered RNA levels upon trr 
knockdown showed Kismet and Trr binding by DamID-Seq, respectively (Figure 6J). This suggests that these 
genes are directly regulated by Kismet and Trr. However, the deregulated genes only represented 10.3% and 
24.3% of the total Kismet and Trr-bound genes, respectively. Therefore, the genetic perturbation of relatively 
general chromatin binding factors can affect a limited subset of genes. This likely underlies the specific 
phenotypes of general chromatin factors noted both here in ISCs and in other contexts, such as during human 
development (Bajpai et al., 2010; Schulz et al., 2014b; Vissers et al., 2004). 
Importantly, we found that 55.5% of the RNAs altered upon knockdown of kismet were also altered 
in trr knockdown (Figure 6I). This represented 19.2% of the trr altered transcripts. Among these genes 
deregulated both upon kismet and trr knockdowns 80.2% are in the same direction, with a decrease in transcript 
level (Figure 6I). 
Overall, these data strongly support our hypothesis that Kismet and Trr co-bind throughout the genome 
and co-regulate gene expression. 
 
Kismet and Trr promote expression of the E3 ligase Cbl, to maintain low levels of the EGF Receptor 
Our previous data indicated that kismet mutant ISCs have increased EGFR signaling (Figure 3A-G). 
Similarly, upon trr knockdown, we found deregulation of dpERK (Figure S7A-B’). The similarities in loss of 
function phenotypes of kismet and trr, the colocalization in the genome, the co-regulation of many genes, and 
deregulation of EGFR signaling led us to propose that Kismet and the Trr-Complex act together to limit ISC 
self-renewal through EGFR regulation. 
Assessing our DamID-Seq and RNAseq data for regulators of EGFR signaling, we identified Cbl, 
encoding an E3 ligase known to promote degradation of EGFR (Duan et al., 2003; Hime et al., 1997; Levkowitz 
et al., 1999; Meisner et al., 1997; Pai et al., 2000; Soubeyran et al., 2002). Cbl was bound by both Kismet and 
Trr and, long and short isoforms of Cbl were downregulated upon inactivation of kismet and trr (Figure 6H, 
K, L). Of note, none of the core components of the Hippo pathway are deregulated upon kismet knockdown 
arguing against this pathway being involved in initiation of kismet mutant phenotypes. If Kismet and Trr 
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control the levels of EGFR via Cbl, then kismet and trr knockdown contexts would lead to increased EGFR 
protein. Clones expressing RNAi against Cbl, kismet or mutant for kismet, had a strong increase in EGFR 
levels, both in clones at 10 days AHS and upon 3 day induction in ISCs (Figure 6M-O’ and S6O-R’, T). 
Knockdown of trr also showed increased EGFR levels in 10 days clones (Figure 6P, P’), although upon 3 day 
knockdown in ISC, this was less pronounced than that of kismet knockdown (Figure S6Q, S-T), consistent 
with Cbl transcripts being less reduced upon trr knockdown than upon kismet knockdown (Figure 6K). 
Furthermore, the expression of Cbl-L isoform (but not Cbl-S) in kismet RNAi expressing clones rescued clone 
size and accumulation of Delta+ cells supporting that Cbl acts downstream of Kismet to regulate ISC self-
renewal (Figure 7A-H). In agreement with previous work (Jiang et al., 2011), the knockdown of Cbl led to 
larger clones with increased numbers of Dl+ ISCs and excessive proliferation (Figure 7I-O). In addition, trr 
mutant phenotypes could be suppressed by conditions that lowered EGFR signaling (expression of EGFR-DN 
or cic; Figure 7P-W). 
Finally, if kismet and trr act on similar target genes, we would predict that their combined phenotype 
would be like kismet mutants, which is indeed what was found (Figure S7C-G). Altogether our data suggest 
than one of the downstream targets of Kismet and Trr required to maintain a basal level of ISC proliferation is 
the E3 ligase encoding gene Cbl, which modulates EGFR protein levels and signaling activation. 
 
Discussion 
 Through an unbiased genetic screen, we have identified the chromatin remodeling factor 
Kismet/CHD7/CHD8, as a regulator of stem cell proliferation in the fly intestine. By establishing the first 
genome-wide binding map of Kismet in Drosophila, our data revealed a large overlap with transcriptionally 
active regions. Interestingly, our genome-wide mapping and RNAseq data suggest that Kismet mediates its 
role on ISCs through collaboration with the Trr-Complex and that the negative regulator of EGFR, Cbl, is one 
critical downstream direct target of kismet and trr, leading to the deregulation of EGFR signaling. Altogether, 
our data uncover an important level of chromatin regulation required to dampen the ISC proliferative response 
in routine homeostasis. 
 In response to homeostatic cell turnover and induced damage, many signaling pathways regulate ISC 
proliferation rates, though how chromatin regulation impinges on this was not understood. Our data show that 
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Kismet and Trr play essential roles in preventing excess ISC proliferation through limiting EGFR signaling, 
which may be required after stress for return to basal levels of proliferation. In addition to EGFR signaling, 
we find that inhibition of additional pathways can suppress kismet phenotypes, reminiscent to “niche 
appropriation” described for Notch mutant tissue: after initial deregulation of stem cell proliferation and local 
tissue perturbation due to Notch inactivation, multiple signaling pathways become activated, including Jnk and 
Jak/Stat signaling, which function together to further drive ISC proliferation (Patel et al., 2015). Thus, our 
findings suggest that niche appropriation is a general property of rapidly proliferating tissues that create stress 
signals in the gut, further fueling cell division. 
 Interestingly, our findings suggested that Kismet is enriched at genes that are expressed not only in 
ISCs, but also at subset of genes that are OFF in the stem cell but will be later turned ON during the 
differentiation process. Of note, we did not detect obvious defects in terminal cell fate differentiation in kismet 
mutant clones using well-characterized markers of EE and EC cells. Further analysis of kismet mutant EE and 
EC cells will determine if there are more subtle defects in differentiation or not. This raises the possibility that 
Kismet may be a good marker of pre-patterning of lineage-specific genes. 
 Our data suggest that Kismet cooperates with the Trr-complex to regulate many genes. CHARGE 
syndrome, due to heterozygous mutation of CHD7 in humans, has extensive phenotypic overlap with Kabuki 
syndrome, caused by mutation of MLL4 (also known as KMT2D and MLL2) and UTX (also known as KDM6A) 
(Butcher et al., 2017; Miyake et al., 2013; Ng et al., 2010; Schulz et al., 2014a). These data raise the question 
of a similar collaboration between these enzymes in human development. The Trr/MLL3/4-Complexes 
establishes the H3K4me1 mark, enriched at primed and active enhancers and, to some extent, promoters. Could 
Kismet/CHD7 remodeling activity promote H3K4me1? Our data argue against this since H3K4me1 was 
reduced in the gut upon knock-down of trr and lpt (Figure S7L-N’), but not altered in kismet mutant clones 
(Figure S7O, O’). In addition, no obvious defects were detected in Histone H3K27ac in kismet mutant clones 
(Figure S6M-N’) or protein levels of Trr in kismet mutants or of Kismet in trr mutants were found (Figure 
S7H-K’). It is possible, however, that Kismet/CHD7 might promote the methyltransferase-independent activity 
of Trr/MLL3/4 that has been shown to regulate enhancer efficiency (Dorighi et al., 2017; Rickels et al., 2017). 
Further evidence suggesting a molecular link between Kismet/CHD7/CHD8 and the Trr/MLL3/4-Complex 
comes from co-IP between Kismet and CBP, a binding partner of the Trr-Complex component Utx and  
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between CHD7/CHD8 and the MLL3/4-Complex components WDR, ASH2L and RbBP5 (Schulz et al., 
2014a; Thompson et al., 2008; Tie et al., 2012). Thus, we speculate that Kismet and the Trr-Complex may 
both be necessary for regulation of a  subset of genes, such as Cbl. 
 In addition to similar phenotypes of CHD7 and MLL4 mutations on human development, both CHD7 
and MLL3/4-complex components are mutated in cancers. CHD7 is found as a highly expressed fusion protein 
in small cell lung cancers (Pleasance et al., 2010). A subset of colorectal carcinomas and gastric cancers were 
found to have frequent mutations in both CHD7 and its closely related gene, CHD8 (Kim et al., 2011; Sawada 
et al., 2013; Tahara et al., 2014). Mutations in CHD7 and in the MLL3/4-Complex are frequently found in 
medulloblastoma and MLL3/4 is also found inactivated in many additional cancers (Ford and Dingwall, 2015; 
Robinson et al., 2012). How deregulating CHD7 and MLL3/4 may impact cancer progression is not entirely 
clear, though recent studies linking enhancer and super-enhancer deregulation to cancer formation suggest that 
the deregulation of enhancers upon mutation of Kismet/CHD7 and Trr/MLL3/4-complex could drive aberrant 
proliferation (Herz et al., 2014; Hnisz et al., 2013). While much of what we know about chromatin regulation 
in stem cells comes from studies of cultured embryonic stem cells, our work provides insight into in vivo roles 
of chromatin remodeling factors in control of adult stem cell self-renewal and proliferation programs. Our 
findings that Kismet and the Trr-Complex loss lead to dramatic alteration of ISC proliferation indicate that the 
Drosophila intestine will be a useful model to probe the relationship between chromatin regulation and stem 
cell proliferation control. 
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Figure legends 
Figure 1. Loss of kismet provokes ISC accumulation without affecting terminal differentiation 
(A) The ISC divide to self-renew and to produce a precursor cell, the EB, that subsequently terminally differentiates 
into an EC or is thought to divide once as an EEP to produce two EE cells. (B-C) Wild-type (B) and kis10D26 mutant 
(C) MARCM clones, 5 days after heat shock (AHS). (D) Quantification of B, C. (E) Scheme of wild-type and 
kismet mutant clones. (F) Scheme of kismet gene and Kismet protein (Long and short isoforms: Kis L and Kis S): 
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chromodomains (RED), ATPase domain (GREEN), BRK domain (BLUE). All kis alleles resulted in nonsense 
mutations: nucleotide changes and corresponding putative resulting truncated proteins are shown. (G-L) Wild-type 
and kis10D26 MARCM clones at 9 days AHS. Arrows in (G-H’) and (I-J’) show EE cells marked by DH31 or LTK2 
respectively. (M-P) Quantification of the total cells per clone (M); of the number of EE cells per clone (Prospero+) 
(N); the number of ECs (Pdm1+ cells per clone) (O); and the ratio of EE (prospero+ cells / EC (polyploid nucleus 
>7µm) per clone (P). (Q, R) Vertical sections through the midgut epithelium of control (Q) and kis10D26 mutant (R) 
MARCM clones, 9 days AHS. Arrows show apical membrane. In (D, M-P) A two-tailed Mann-Whitney statistical 
test was used, mean values in RED, error bars=SEM. Scale bars = 20µm. 
 
Figure 2. Loss of kismet activity promotes ISC proliferation 
(A, B) Wild-type (A), and kis10D26 (B), MARCM clones at 30 days AHS. (C, D) Quantification of the percent of 
clones with at least one PH3+ cell (C) and the average number of PH3+ cell per clone (D) from (E-F’). (E, E’, F, 
F') Wild-type (E, E’), and kis10D26 (F, F’), 9 days AHS MARCM clones (arrows show PH3+ cells). (G, H) Wild-
type (G), and kis10D26 (H), MARCM clones 9 days AHS expressing UAS-GFP-E2f1-230, UAS-mRFP-CycB1-266 
FUCCI system allowing cell cycle stage determination (G1: nuclear GFP+; S: RFP+; and G2/M: GFP+ and RFP+; 
arrowheads show Delta+ ISCs). (I) Quantification of the percent ISCs (from G, H). (J) Mean Kismet fluorescence 
intensity normalized by mean DAPI staining in ISCs (esg+), EEs (diploid esg-) and ECs (polyploid cells) from (K-
K’). (K, K’) Kismet showed ubiquitous nuclear expression with a stronger accumulation in esg+ progenitor cells 
(ISCs and EBs) marked by GFP and EE cells (diploid GFP-). (L, L’) kismet RNAi expressing clones, 9 days AHS, 
had depleted Kismet protein and reproduced kis10D26 phenotypes. (M, N) Quantification of the number of cells per 
clone (M) and ISCs (Delta+) per clone (N) in wild-type and kis RNAis expressing clones. (O, P, Q) ISC-specific 
expression of kis RNAis for 10 days at 29°C. (R) Quantification of the number of PH3+ cells per posterior midgut 
expressing kis RNAi in the ISCs/EBs (esgts driver), in ISCs only (esgts- NREGAL80 driver), in EBs only (NREts), 
in ECs only (Myo1Ats) for 10 days, or in EE cells (prosts) for 10 days. A Fisher’s exact test was used in (C). A two-
tailed Mann-Whitney test was used in (D, J, M, N, R).  A Chi2 test was used for (I). Mean values in RED; error 
bars=SEM. Scale bars = 20 µm. 
 
Figure 3. Kismet controls proliferation by regulating EGFR pathway activity 
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(A-D’) Wild-type (A, A’, C, C’), and kis10D26 (B, B’, D, D’), 9 days AHS MARCM clones. EGFR signaling, detected 
by dpERK (A-B’) and EGFR target CycE-LacZ (C-D’), was increased in kis10D26 clones. (E-F’) Wild-type (E, E’), 
and kis10D26 (F, F’), 3 days AHS MARCM clones expressing CycE-LacZ. (G) Proportion of ISCs expressing CycE-
lacZ from (E, F’). (H, I) ISC-specific expression of GFP (H) or kis RNAi (BL34908) (I), 3 days at 29°C. (J) 
Quantification of proportion of ISCs showing strong, weak or no dpERK from (H-I’). (K-N) 12 days AHS clones: 
wild-type (K), kis10D26 mutant (L), expressing UAS-EGFRDN (M) and kis10D26 mutant expressing UAS-EGFRDN (N). (O) 
Clone size, number of Delta+ cells/clone, and % of Delta+ cells/clone from (K-N). (P, Q) 10 days AHS clones: 
wild-type expressing cic (P), and kis10D26 mutant expressing cic (Q). (R) Clone size, number of Delta+ cells/ clone, 
and % of Delta+ cells/clone from (P, Q). Results compared using a Chi2 test in (G, J) and a two-tailed Mann-
Whitney test in (O, R). Mean values in RED, error bars=SEM. Arrows highlight ISCs. Scale bars = 20 µm.  
 
Figure 4. Genome-wide mapping of Kismet relative to RNA Pol II, Brm, Pc, HP1 and H1 
(A) Kismet DamID-Seq showed an enrichment of methylated GATCs in the introns and 5’UTR regions of genes. 
Unassembled regions of the genome were not considered. (B) Genome-wide overview of the DamID binding peak 
density in ISCs of Kismet, RNA Pol II, Polycomb (Pc), Brahma (Brm), HP1 and H1. (C) UMAP clustering of 
GATC sites based on 7 DamID fusion proteins (see Star Methods) in the ISC. Density of GATC sites throughout 
the genome used for clustering followed by the plots representing the binding of each protein over GATC sites. (D-
I) Venn diagrams of genes with peaks of the DamID-Seq data in ISCs: Kismet vs HP1 or H1 (D) vs Pc (E) vs RNA 
Pol II (F) and vs Brm (G). Genes with a significant mean RNA Pol II occupancy determined by DamID vs 
transcriptionally active genes based on RNAseq from (Dutta et al., 2015) (H) and vs genes with peaks of Kismet 
(I). (J) Mean position and metaplot of Kismet, RNA Pol II and Pc in ISCs relative to the TSS for genes classified 
by their activity based on RNA Pol II occupancy. Kismet was significantly enriched over the TSS of active genes. 
(K) Mean position and metaplot of Kismet and RNA Pol II in ISC relative to previously defined “developmental” 
or “housekeeping” enhancers in S2 cells from (Zabidi et al., 2015). Kismet was found enriched over developmental 
enhancers. (L) Wild-type RNA seq, Dam-Kis, Dam-RNA Pol II, Dam-Pc, Dam-Brm, Dam-HP1 and Dam-H1 ISC 
binding profiles and peaks alignments over the genomic region surrounding the ISC-specific gene Delta.  
 
Figure 5. Loss of Trr COMPASS-like complex activity induces abnormal ISC accumulation 
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(A-D) Wild-type (A), trr RNAi (B), lpt RNAi (C), or Utx RNAi (D) at 9 days AHS clones. (E, F) Average number 
of cells (E) and ISCs (F) per clone from (A-D). (G-G’) Utx was ubiquitously expressed, but enriched in esg>GFP+ 
cells and in EE (esg>GFP- diploid cells). (H) Mean Utx staining fluorescence intensity normalized by the mean 
DAPI staining in ISCs, EEs and ECs (polyploid cells) from (G-G’). (I-I’) Lpt was ubiquitously expressed but 
enriched in EE cells (diploid, esg>GFP-). (J, J’) Trr was uniformly expressed in all midgut cell types. In (E, F, H) 
a two-tailed Mann-Whitney statistical test was used. Mean values in RED; error bars= SEM. Scale bars=20 µm. 
 
Figure 6. Genome-wide mapping of Trr DNA binding sites and gene regulated by Kismet and Trr 
(A) Kismet and Trr localization on polytene chromosomes of the salivary gland. (B-B”) Magnification of the 
chromosome highlighted in (A). Fluorescent intensity in (B’’). (C) Trr binding in the ISC clustered using UMAP 
based on 7 DamID fusion proteins (Star Methods and Figure 4C). (D) Mean position and metaplot of Trr in ISCs 
plotted relative to the TSS for genes according to their activity based on RNA Pol II occupancy shows its enrichment 
over the TSS of active genes. (E) Mean position and metaplot of Trr in ISC over previously defined 
“developmental” or “housekeeping” enhancers in S2 cells from (Zabidi et al., 2015). (F) Overlap between genes 
with peaks of Kismet vs Trr. (G) Principal component analysis of RNAseq. (H) Differentially expressed genes; 
RED points highlight common genes. (I) Upper: overlap between genes with RNAs deregulated upon kis and trr 
knockdown in the ISCs. Lower: proportion of RNAs altered in kis and trr knockdown. (J) Upper: genes with peaks 
of Kismet and deregulated after kis knockdown in the ISCs. Lower: genes with peaks of Trr and deregulated after 
trr KD in the ISCs. (K) RNAseq data showing downregulation of the 2 Cbl isoforms upon either kis RNAi and trr 
RNAi in the ISC. (L) Wild-type RNAseq, Kismet, Trr, RNA Pol II, Pc, Brm, HP1, H1 binding profiles and peaks 
as determined by DamID-Seq in the ISCs, alignments at the Cbl locus. (M-P’) clone of wild-type (M, M’), Cbl 
RNAi (N, N’), kis10D26 (O, O’) and trr RNAi (P, P’), 10 days AHS. Arrows show EGFR positive cells. Scale bars=20 
µm. 
 
Figure 7. Trr and Kismet regulates EGFR activity through the control of Cbl expression 
(A-F) Clone of wild-type (A), kis RNAi34908 (B), UAS-Cbl-L  (C), both kis RNAi34908 and UAS-Cbl-L (D), UAS-Cbl-
S (E), and both kis RNAi34908 and UAS-Cbl-S (F) at 9 days AHS. (G, H) Average number of cells and ISC/clone 
from (A-F). (I, J) Clones of wild-type (I) and Cbl RNAi (J) 10 days AHS. (K, L) Average number of cells and 
ISC/clone from (I, J). (M, N) ISC specific expression of GFP (M) and Cbl RNAi (N) driven by esgts- NREGAL80 
 20 
for 10 days at 29°C. Cbl knockdown results in an accumulation of GFP, Delta+ cells. (O) Quantification of number 
of PH3+ cells per gut from (M, N). (P-U) Clone of wild-type (P), trr RNAi (Q), UAS-EGFRDN  (R), both trr RNAi 
and UAS-EGFRDN (S), UAS-cic (T), and both trr RNAi and UAS-cic (U) at 10 days AHS. (V, W) Clone size (V) 
and number of Delta+/clone (W) from (P-U). Results were compared using two-tailed Mann-Whitney statistical 
test. Mean values in RED, error bars=SEM. Scale bars=20 µm. 
 
STAR METHODS 
CONTACT FOR REAGENT AND RESOURCE SHARING  
Further information and requests for resources and reagents should be directed to and will be fulfilled by the 
Lead Contact, Allison Bardin (allison.bardin@curie.fr). 
EXPERIMENTAL MODEL AND SUBJECT DETAILS  
Flies were kept in yeasted tubes at 25°C unless mentioned. The following fly stocks were used in this study: 
FRT40A kis10D26 (from C.P., F.S., A.J.B., unpublished genetic screen),  kis1 (#431), UAS-kis-RNAi (#36597) 
for Figure 2L-P, R; S2 A-E’, G, I, K, M and UAS-kismet RNAi #34908 for Figures 2M, N and Q; 3I, J; 7B, F; 
S6Q, R, T and for kismet knockdown RNA-seq condition), UAS-lpt-RNAi (#25994), UAS-trr-RNAi (#29563), 
UAS-utx-RNAi (#34076), FR82B trxE2 (#24160), FRT19A trrB encoding a putative truncated 512 aa protein 
(#57138), UAS-EGFRDN (#5364), UAS-bskDN (#6409), UAS-yki-RNAi (#34067), UAS-InRDN (#8253), UAS-
domeRNAi (#34618), UAS-ash1-RNAi (#31050 and #36130), UAS-brm-RNAi (#31712), UAS-Cbl-RNAi 
(#27500), UAS-GFP-E2f1-230, UAS-mRFP-CycB1-266 (#55118), 10XSTAT92E-GFP (#26198), CycE-lacZ 
(#30722), (From the Bloomington Drosophila Stock Center, BDSC), UAS-set1-RNAi (#40682), UAS-cic-RNAi 
(#103805) (From the Vienna Drosophila RNAi Center, VDRC), kisLM27 and kisEC1 (Melicharek et al., 2008),  
NRE-LacZ (Furriols and Bray, 2001), Nintra: UAS-Notchcdc10 is a truncated active version of intracellular 
Notch, (Brennan et al., 1999), UAS-LT3-NDam and UAS-LT3-NDam-RNAPol II (Southall et al., 2013) UAS-
LT3-Dam-Pc, UAS-LT3-Dam-HP1a, UAS-LT3-Dam-Brm and UAS-LT3-Dam-H1 (Marshall and Brand, 
2017), UAS-cicHA (Jin et al., 2015), pucE69-LacZ (gift from N.Tapon), Upd-LacZ and Upd3.1-LacZ (gift from 
B. Edgar), UAS-Cbl-L and UAS-Cbl-S (gift from L.M. Pai). The following Gal4 drivers were used: NRE-
GAL4 ; tubGAL80ts UAS-GFP (NREts) (Zeng et al., 2010), esg-GAL4, tubGAL80ts UAS-GFP (esgts) (Jiang et 
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al., 2009), esg-GAL4, Su(H)GBE-GAL80 tubGAL80ts (esgts, NREGAL80) (Wang et al., 2014), MyoIAGAL4; 
tubGAL80ts UAS-GFP (Myo1Ats) (Jiang et al., 2009). prosvoila-Gal4, tub-Gal80ts (prosts) (Balakireva et al., 
1998). 
METHOD DETAILS  
Generation of transgenic flies 
 kislocus construct containing 524 bp upstream to 12 kb downstream of the kis gene was generated 
starting from Drosophila BAC (P[acman] BAC CH321-35E09) that was further altered by recombineering to 
reduce the genomic size and to add a FLAP cassette N-terminally (amplified from the plasmid R6kam-hNGFP; 
kindly provided by T. Hyman). The FLAP cassette is composed of green fluorescent protein (GFP), S- and 
Flag-affinity tags separated by PreScission- and TEV- protease sites. Transgenic flies were generated at 
Bestgene, Inc. by injection of attP-9AVK00013. To generate UAS-kisL and UAS-kisS transgenic flies, kis-RA 
and kis-RB cDNA were respectively amplified from a midgut library and then inserted into the pUASPattB 
plasmid and tagged with both a 6xHIS N-terminal and a FLAG C-terminal cassette for kis-RA and only by a 
FLAG C-terminal cassette for kis-RB. Transgenic flies were generated at Bestgene, Inc. by injection of attP-
3BVK00033 embryos. The mutation of Chd7 K999R, a residue in the highly conserved ATP binding motif of 
SNF2 superfamily proteins, was shown to prevent its ATPase catalytic activity (Bouazoune and Kingston, 
2012). We therefore made the equivalent K2060R mutation in Kismet coding sequence. To generate UAS-kis-
K2060R transgenic flies, the mutation G>A at 2060th codon was inserted into the pUASP-6His_kis-PA_Flag 
BAC plasmid by recombineering using the rpsl/neo positive and counterselection system. The final plasmid 
was tagged with both a 6xHIS N-terminal and a FLAG C-terminal cassettes. Transgenic flies were generated 
at Bestgene, Inc. by injection of attP-3B-VK00033 embryos. To generate UAS-Dam-kis transgenic, UAST-
mCherry-NDam-Myc sequences amplified from the pUASTattB-LT3-NDam plasmid (Southall et al., 2013) 
were inserted N-terminally to kis-RA cDNA attB containing vector followed by injection by Bestgene, Inc of 
attP2 embryos. To generate UAS-Dam-trr transgenic, the trr sequence from the ATG to stop codon was 
obtained starting from Drosophila BAC CH322-128O7 that was further altered by recombineering to reduce 
the genomic size and amplified before insertion C-terminally to Myc into UAST-mCherry-NDam-Myc plasmid 
by Gibson Cloning method followed by injection by Bestgene, Inc of P{CaryP}attP2 embryos with the plasmid 
together with a phiC31 integrase helper plasmid pBS130 as an integrase source. 
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 Clonal analysis and Gal4 expression 
 Clones were generated with the Mosaic Analysis with Repressible Cell Marker (MARCM) technique 
(Lee and Luo, 1999). The following fly stocks where used for MARCM: hsflp122 P[pTub-GAL80] FRT19A; 
P[pAct-GAL4] (Lin et al., 2008) to produce GFP marked clones on the X chromosome and P[UASGFP]w 
P[hs-FLP] P[pTub-GAL4] P[UAS-nlsGFP] associated with either FRT40A P[pTub-GAL80] or FRT82B 
P[pTub-GAL80] to produce GFP marked clones on the second or the third chromosome respectively, w P[hs-
FLP]; FRT40A P[pTub-GAL80]; P[UAS-RFP], P[pTub-GAL4] to produce RFP marked clones on the second 
chromosome and w P[hs-FLP]; FRT40A P[pTub-GAL80]; P[pTub-GAL4] to produce clones expressing UAS-
GFP-E2f1-230, UAS-mRFP-CycB1-266 FUCCI system. MARCM Clones were induced with a heat shock (35 min 
at 36.5°C) on 3-day-old adult females and were dissected 5, 9, 10, 12 or 30 days after heat shock. 
 MARCMts clones were generated using the following stock: w P[hs-FLP] P[pTub-GAL4] P[UAS-
nlsGFP]; FRT40A P[pTub-GAL80]; P[pTub-GAL80ts]. Crosses were maintained at 18°C, before and after 35 
minutes heat shock clone induction at 36.5°C in 3-day-old adult females. 10 days AHS, temperature was shifted 
to 29°C for 3 days before dissection to allow transgenes expression (UAS-GFP and UAS-NAct). 
 For temporal cell type-specific expression of kismet RNAi we used the temperature sensitive inducible 
UAS-GAL4/GAL80ts system. Crosses and adults were kept at 18°C, the GAL80 permissive temperature. 3 day 
old flies were shifted to 29°C for 2, 3 or 10 days to induce RNAi expression. 
 
Immunofluorescence and imaging 
 As described previously (Bardin et al., 2010), adult female midguts were dissected in PBS and then 
fixed at room temperature (RT) for 2 hours in 4% paraformaldehyde. Gut were trimmed and incubated in PBS 
50% glycerol for 30 minutes before equilibration in PBS 0.1% Triton X-100 (PBT) to clean the lumen. For 
anti-NotchECD staining, guts were fixed for 15 min in 4% formaldehyde/heptane followed methanol treatment 
and rehydration in PBT as described in (Lin et al., 2008). Fixed samples were then washed in PBT for at least 
30 min before addition of primary antibodies (overnight at 4°C or 3-5 hours at RT). After at least 30 min wash, 
secondary antibodies were incubated 3-5 hours before DAPI staining (1 µg/ml) and mounted in 4% N-propyl-
galate, 80% glycerol. Polytene immunostainings were performed on L3 larvae salivary glands chromosomes 
as described in (Zink and Paro, 1995). Salivary glands were fixed in droplet of 45% acetic acid for 3 min. The 
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coverslip was placed onto a poly-L-lysine coated slide and tapped using the tip of a pencil to spread the 
chromosomes. The quality of the preparations was checked under phase contrast microscope. Slides were next 
snap-frozen in liquid nitrogen, and coverslip removed. Slides were immediately put in PBS before replacement 
by blocking solution (1% BSA, 0.5% Triton X100 in PBS) for 1 hour at RT. 50µl of primary antibody in 
blocking solution was placed onto the chromosome spreads in a humid chamber (1 hour at 4ºC). Slides were 
washed in PBS 0.5% triton for 15 minutes. Secondary antibodies were incubated for 1 hour before DAPI 
staining (1µg/ml) and mounted in 4% N-propyl-galate, 80% glycerol. 
The following primary antibodies were used: anti-Delta ECD C594.9B (mouse,1:2000, 
Developmental Studies Hybridoma Bank (DSHB)); anti-GFP (chicken, 1:2000, Abcam), anti-DsRed (rabbit, 
1;1000, Clontech), anti-Sanpodo (rabbit, 1:1000; J. Skeath), anti-Notch ECD C458.2H (mouse, 1:100, DSHB), 
anti-ßGAL (goat, 1:500; Biogenesis), anti-Prospero (mouse, MR1A; 1:1000; DSHB), anti-Pdm1 (rabbit, 
1:1000; X. Yang), anti-PH3 (rabbit, 1:1000; Millipore), anti-Kismet DK20 (goat, 1:500; Santa Cruz), anti-Utx, 
anti-Trr, anti-Lpt and anti-H3K4me1 (Rabbit, 1:500 (Herz et al., 2012)), anti-dpERK (Rabbit, 1:200; Cell 
Signaling Technology), anti-H3K27me3 (Rabbit, 1:500; Diagenode), anti-H3K27ac (Rabbit, 1:2000; Abcam), 
anti-EGFR (Mouse, 1:100, Sigma), anti-DH31 (Rabbit, 1:500, J.A Veenstra), anti-LTK2 (Rabbit, 1:1000 J.A 
Veenstra) and Alexa 647-conjugated phalloidin (1:100, LifeTechnologies). Imaging was performed using 
Zeiss LSM700 and LSM780 confocal microscopes at the Curie Institute imaging facility with serial optical 
sections taken at 1 to 1.5 µm intervals (512X512 or 1024X1024) using 20X or 40X oil objectives through the 
whole-mounted posterior midguts. Representative images are shown in all panels. Super-resolution image was 
performed with a Structured Imaging Microscope (OMX v3 from Applied Precision-GE Healthcare), equipped 
with 3 EMCCD, Evolve cameras (Photometrics).  
 
DamID-Seq analysis: 
In DamID, the fusion of Dam methyl transferase to a DNA associated protein allows the methylation 
of surrounding GATC sites of DNA, which can be specifically sequenced (Choksi et al., 2006; van Steensel 
and Henikoff, 2000). In targeted DamID-Seq, cell type-specific low level expression is achieved, thereby 
allowing in vivo mapping of chromatin associated factors (Southall et al., 2013).  
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 Using the damidseq_pipeline (Marshall and Brand, 2015) reads in fastq files were aligned to the 
Drosophila melanogaster reference genome version 6 using bowtie2 (Langmead and Salzberg, 2012) and 
alignments were extended to 300 nucleotides or the first GATC site, whichever occurred first. 
 For all GATC sites in mappable regions read coverage was counted using bedtools coverage (Quinlan 
and Hall, 2010). GATC sites with fewer than 5 counts on average were discarded. The remaining GATC sites 
were split into control counts and DamID fusion counts and tested for statistically significant differences using 
DESeq2 (Love et al., 2014), which also estimates a variance stabilized log2 fold enrichment values for each 
GATC site. 
 Peaks were called by merging 2 or more consecutive significant GATC sites (adjusted p-value < 0.01, 
log2 fold change > 0). Genes were classified as bound by a protein if 2 consecutive GATC sites within the 
gene body were occupied with an adjusted p-value < 0.01. 
Metaplots were produced using deepTools plotHeatmap (Ramírez et al., 2014) using the DESeq2 
output that was converted into bigwig files. Developmental and housekeeping S2 cells enhancers are defined 
in (Zabidi et al., 2015). Lists of expressed genes and cell type-specific genes were generated from published 
RNAseq data in the gut (Dutta et al., 2015). All genes with rpkm >1 in the ISC were considered as significantly 
expressed. Lists of genes enriched in each cell type (ISC, EC, EE) were generated by applying the following 
criteria: (1) the gene rpkm in one specific cell type is at least 2 times higher than the rpkm in each of the other 
cell types, (2) the gene rpkm in each other cell type is <2. Lists of EE-enriched genes and EC-enriched genes 
were merged to generate the list of differentiated cell types-enriched genes. 
 For the calculation of distribution of Kismet bound GATC sites in the genome in Figure 4A the 
Drosophila gene annotation GTF was downloaded from flybase version 6.13 (Gramates et al., 2017). The GTF 
file was filtered to retain only 3’UTR coding, 5’UTR coding, exon and gene features. The file was then split 
into a single file per genomic feature and overlapping features were merged using bedtools. Using bedtools 
subtract, exonic regions were subtracted from genic regions to obtain intronic regions, and exonic regions were 
subtracted from overlapping 3’UTR and 5’UTR coding regions. Significantly bound GATC sites were 
classified as belonging to one of these regions using bedtools intersect. 
 RNA Pol II occupancy was determined by considering mean ratios (Dam-RNA Pol II/Dam-only) 
across annotated transcripts using “polii.gene.call” script and false discovery rates (FDR) were assigned 
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(Marshall and Brand, 2015; Southall et al., 2013). Genes with an FDR < 0.01 were used as genes active in ISC 
(Figure 4 J and 6D. 
All analysis has been done on Galaxy (Afgan et al., 2016).  
 A 2D UMAP embedding (McInnes et al., 2018) was created from the log2 values estimated by 
DESeq2. To evaluate the embedding we plotted the log2 value for each GATC and each chromatin protein in 
the UMAP coordinates. We explored effect of varying the n_neighbors, min_dist, n_components and metric 
parameter and note that varying the parameters results in very similar maps. The parameters used are 
n_neighbors=30, min_dist=0.0, n_components=2, random_state=42, metric='canberra'.  
 
RNAseq analysis: 
 For transcriptome profiling of sorted ISC, 3 days old females with either UAS-GFP with UAS-white-
RNAi (control), or with UAS-kis RNAi or with UAS-trr-RNAi under the control of esgts NREGal80 were shifted 
from 18°C to 29°C for 2 days to induce RNAi expression. For each biological replicate (n=3 for control, n=4 
for kis-RNAi, n=3 for trr-RNAi) Midguts from 100 females were dissected in PBS before FACS sorting 
isolation of ISC GFP+ cells followed by RNA isolation and amplification as described in (Dutta et al., 2013). 
Reads were quasi-mapped against the Drosophila reference transcriptome fasta (Flybase, release 6.13) using 
Salmon (Patro et al., 2017). Differential gene expression testing was performed using tximportData, RUVseq 
(Risso et al., 2014) and DESeq2. Genes with an adjusted p-value < 0.01 were considered differentially 
expressed. All analysis has been done on Galaxy (Afgan et al., 2016).  
 
QUANTIFICATION AND STATISTICAL ANALYSIS  
Quantification and statistical analysis 
 Image acquisition was followed by data processing with Fiji software and assembled using Adobe 
Photoshop. Images were processed with a median filter of 1 pixel width before applying Z-stack max 
projections. All quantification of clonal analysis was limited to the posterior midgut and only clones containing 
two or more cells (stem cell clones) were scored except for Figure S3J where 1 cell clones were included. 
Contiguous cells (GFP+ or RFP+) were considered as part of one discrete clone for quantifications. All graphs 
are scatterplots of raw data to present the full distribution of values observed and all statistical analysis were 
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performed using Prism software. PH3+ cells number per gut was evaluated on the entire midgut (Figure 2D). 
In Figure 2J and 5H, Kis and Utx staining intensity were quantified within the posterior midgut. The largest 
nuclear plane for each cell type (esg+ ISC/EB, esg-diploid EE and esg- polyploid Ecs) was determined 
manually and the average fluorescent intensities of Kismet, Utx and DAPI were calculated with Fiji for these 
planes. In Figure 5I-J, EGFR staining intensity in esg+ cells was quantified per square region within each 
posterior midgut. The largest plane for each esg+ cell was determined manually in order to measure the cell 
area and mean fluorescent EGFR intensity with Fiji software and to calculate total EGFR intensity. Statistical 
analysis were performed using the Graphpad Prism softaware and significance calculated by either two-tailed 
Mann-Whitney or chi2 statistical tests with ns for non-significant, * for p<0.05, ** for p<0.01, *** for p<0.001 
and ****p<0.0001. 
 
DATA AND SOFTWARE AVAILABILITY  
Galaxy workflows, IPython notebooks and UMAP code used in the analysis are available at 
https://github.com/bardin-lab/kismet-analysis. DamID data have been deposited in the Gene Expression 
Omnibus (GEO) (accession number GSE128941). 
 
Supplementary Tables 
Table S1. List of gene with Kismet peaks in ISC from Kis DamID-Seq, related to Figure 4. 
This table includes to the list of genes with significant Kismet peaks with their Flybase ID, symbol, name, gene 
start and end and chromosome arm location. 
 
Table S2. RNA Pol II, Polycomb, Brahma, HP1 and histone H1 binding peaks in ISC from DamID-Seq, 
related to Figure 4. 
This table includes the lists of genes with significant peaks for RNA Pol II (Table S2-1), Polycomb (Table S2-2), 
Brahma (Table S2-3), HP1 (Table S2-4) and H1 (Table S2-5) with their Flybase ID, symbol, name, gene start and 
end and chromosome arm location. 
 
Table S3. List of genes with significant RNA Pol II occupancy in the ISC, related to Figure 4. 
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This table includes the list of genes with significant RNA Pol II occupancy in the ISC (FDR<=0.01) as determined 
by ISC RNA Pol II-DamID. 
 
Table S4. Trr binding peaks in ISC from Trr DamID-Seq, related to Figure 6. 
This table includes the list of genes with significant Trr peaks with their Flybase ID, symbol, name, gene start and 
end and chromosome arm location. 
 
Table S5. kis RNAi and trr RNAi RNAseq results, related to Figure 6. 
Table S5-1 corresponds to the list genes deregulated upon kis knockdown. 
Table S5-2 corresponds to the list of genes deregulated upon trr knockdown. 
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Northwestern University 
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Northwestern University 
Feinberg School of Medicine 
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Northwestern University 
Feinberg School of Medicine 
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Feinberg School of Medicine 
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Chemicals, Peptides, and Recombinant Proteins 
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Klenow fragment NEB Cat# 210S 
 
T4 polynucleotide kinase NEB Cat# M0201S 
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Elastase Sigma Cat# E0258-5MG 
   
Critical Commercial Assays 
Qiaquick PCR Purification kit Qiagen Cat# 28104 
QIAmp DNA Micro Kit 
 
Qiagen Cat# 56304 
 
Arcturus PicoPure RNA Isolation Kit  ThermoScientific  Cat# KIT0202 
RNase-Free DNase Set  Qiagen Cat# 79254 
Arcturus™ RiboAmp™ HS PLUS Kit 
 
ThermoScientific Cat# KIT0525  
   
Deposited Data 
Lists of expressed genes and cell type-specific 
genes were generated from published RNAseq 
data in the gut 
 




   
Experimental Models: Organisms/Strains 
Drosophila: FRT40A kis10D26 This study, Institut Curie 
Paris. 
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Drosophila: UAS-domeRNAi  BDSC, 
(Perkins et al., 2015) 
BDSC Cat# 34618, 
RRID:BDSC_3461
8 
Drosophila: UAS-ash1-RNAi # 31050 BDSC, 
(Perkins et al., 2015) 




Drosophila: UAS-ash1-RNAi # 36130 BDSC, 
(Perkins et al., 2015) 
BDSC Cat# 36130, 
RRID:BDSC_3613
0 
Drosophila: UAS-brm-RNAi  BDSC, 
(Perkins et al., 2015) 
BDSC Cat# 31712, 
RRID:BDSC_3171
2 
Drosophila: UAS-Cbl-RNAi  BDSC, 
(Perkins et al., 2015) 






(Zielke et al., 2014) 
BDSC Cat# 55118, 
RRID:BDSC_5511
8 
Drosophila: 10XSTAT92E-GFP  BDSC 
(Ekas et al., 2006) 
BDSC Cat# 26198, 
RRID:BDSC_2619
8 
Drosophila: CycE-lacZ BDSC 
Gift by Helena Richardson, 
Peter MacCallum Cancer 
Centre to BDSC 
BDSC Cat# 30722, 
RRID:BDSC_3072
2 
Drosophila: UAS-set1-RNAi VDRC,  
(Dietzl et al., 2007) 
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Drosophila: UAS-cic-RNAi  VDRC, 
(Dietzl et al., 2007) 
Cat# 103805 
Drosophila: FRT40A kisLM27 Gift from D.R. Marenda, 
Drexel University. 
N/A 
Drosophila: FRT40A kisEC1 Gift from D.R. Marenda N/A 
Drosophila: NRE-LacZ (Furriols and Bray, 2001) N/A 
Drosophila: UAS-Notchcdc10 (Brennan et al., 1999) N/A 
Drosophila: UAS-LT3-NDam-RNAPol II (Southall et al., 2013) N/A 
Drosophila: UAS-LT3-Dam-Pc (Marshall and Brand, 2017) N/A 
Drosophila: UAS-LT3-Dam-HP1a (Marshall and Brand, 2017) N/A 
Drosophila: UAS-LT3-Dam-Brm (Marshall and Brand, 2017) N/A 
Drosophila: UAS-LT3-Dam-H1 (Marshall and Brand, 2017) N/A 
Drosophila: UAS-cicHA (Jin et al., 2015) N/A 
Drosophila: pucE69-LacZ Gift from N.Tapon, Francis 
Crick Institute, London 
N/A 
Drosophila: Upd-LacZ Gift from B.A Edgar, 
Huntsman Cancer Institute, 
Utah 
N/A 
Drosophila: Upd3.1-LacZ Gift from B.A Edgar, 
Huntsman Cancer Institute, 
Utah 
N/A 
Drosophila: UAS-Cbl-L Gift from L.M. Pai, 
Chang Gung University, 
Taiwan 
N/A 
Drosophila: UAS-Cbl-S Gift from L.M. Pai, 
Chang Gung University, 
Taiwan 
N/A 
Drosophila: NRE-GAL4 ; tubGAL80ts UAS-GFP (Zeng et al., 2010) N/A 
Drosophila: esg-GAL4, tubGAL80ts UAS-GFP  (Jiang et al., 2009) N/A 
Drosophila: esg-GAL4 UAS-YFP; Su(H)GBE-
GAL80 tubGAL80ts 
(Wang et al., 2014) N/A 
Drosophila: MyoIAGAL4; tubGAL80ts UAS-GFP (Jiang et al., 2009) N/A 
Drosophila: prosvoila-Gal4, tub-Gal80ts (Balakireva et al., 1998) N/A 
Drosophila: w P[hs-FLP] P[pTub-GAL4] P[UAS-
nlsGFP] 
(Bardin et al., 2010) N/A 
Drosophila: FRT40A P[pTub-GAL80] (Bardin et al., 2010) N/A 
Drosophila: FRT82B P[pTub-GAL80] (Bardin et al., 2010) N/A 
Drosophila: w P[hs-FLP]; FRT40A P[pTub-GAL80]; 
Drosophila: P[UAS-RFP], P[pTub-GAL4] 




Drosophila: hsflp122 P[pTub-GAL80] FRT19A; 
P[pAct-GAL4] P[UASGFP] 
(Lin et al., 2008) N/A 
   
Recombinant DNA 
Drosophila BAC: (P[acman] BAC CH322-128O7) BACPAC Resources Center CH322-128O7 
Drosophila BAC: (P[acman] BAC CH321-35E09) BACPAC Resources Center CH321-35E9 
Plasmid: kislocus-FLP This paper, Institut Curie, 
Paris. 
N/A 
Plasmid: R6kam-hNGFP Gift from AA. Hyman, 
Max Planck Institute, 
Dresden. 
N/A 
Plasmid: UAS- KisS-Flag This paper, Institut Curie, 
Paris. 
N/A 
Plasmid: UAS-KisL-His-Flag This paper, Institut Curie, 
Paris. 
N/A 
Plasmid: UAS-kis-K2060R-His-Flag This paper, Institut Curie, 
Paris. 
N/A 
Plasmid: pUASTattB-LT3-NDam (Southall et al., 2013) N/A 
Plasmid: UAS-LT3-Dam-Kis This paper, Institut Curie, 
Paris. 
N/A 
Plasmid: UAS-LT3-Dam-Trr This paper, Institut Curie, 
Paris. 
N/A 
   
Software and Algorithms 
Prism 7  GraphPad Software RRID:SCR_00279
8 
FIJI  https://fiji.sc  N/A 
Damidseq_pipeline  (Marshall and Brand, 2015) https://owenjm.gith
ub.io/ 






bedtools (Quinlan and Hall, 2010) https://bedtools.rea
dthedocs.io/en/late
st/index.html 








polii.gene.call (Marshall and Brand, 2015) https://owenjm.gith
ub.io/ 
Galaxy (Afgan et al., 2016) https://usegalaxy.o
rg 











Supplemental Figures and Legends 
 
Figure S1. Characterization of other kismet mutant alleles and rescue experiments, related to 
Figure 1. 
(A, B) Wild-type control (A) and kis10D26 mutant (B) MARCM clones, 5 days AHS (GFP, GREEN; 
Sanpodo (Spdo), RED). (C-E) A wild-type clone (C), a kis10D26 mutant clone (D), and a kis10D26 
mutant clone with one copy of genomic rescue construct that partially rescued the kis mutant 
phenotype (E; kislocus), at 9 days AHS. (F) Quantification of the cells per clone, and the Delta+ cells 
per clone from (C-E). (G-L) Control clones over-expressing kisL cDNA (G), kisS cDNA (I), or 
kisK2060R cDNA a kis ATPase dead domain form of kismet (K) and kis10D26 mutant clones over-
expressing kisL (H), kisS (J) or kisK2060R (L) 9 days AHS (GFP, GREEN; DAPI, BLUE, Delta, RED). 
(M, N) Quantification of cells per clone (M), and Delta+ cells per clone (N) from (G-L). (O-T) 
Mutant clones for kisEC1 (O), kisLM27 (Q), and kis1 (S) alone or over-expressing kisL cDNA (P), (R) 
and (T), respectively, 9 days AHS (GFP, GREEN; DAPI, BLUE; Delta, RED). (U, V) Quantification 
of cells per clone (U), and Delta+ cells per clone (V) from (O-T). Results were compared using a 
two-tailed Mann-Whitney statistical test. Mean values in RED, error bars= SEM. Scale bars=20 µm. 
 
Figure S2. Kismet is not required in EBs and ECs to control ISC accumulation, related to 
Figure 2. 
(A-E’) 2 day kis RNAi (BL36597) expression in the ISCs/EBs driven by esgts (A, A’), in ISCs only 
driven by esgts- NREGAL80 (B, B’), in the ECs driven by Myots (C,C’), in the EBs driven by NREts 
(D, D’), or in the EEs driven by prosts (E, E’) was sufficient to deplete Kismet protein (GFP, 
GREEN; DAPI, BLUE; Kismet, WHITE). Arrows point toward cells with depleted Kismet). (F, G) 
esgts driven expression of GFP only (F) or with a kis RNAi (BL36597) (G) in ISCs and EBs for 10 
days at 29°C. kismet ISCs/EBs knockdown induced an increase in esg+ (GFP, GREEN), and Delta+ 
cells (RED) compared with control (DAPI, BLUE). (H, I) Myots driven expression of GFP only (H) 
or along with a kis RNAi (BL36597) (I) in ECs for 10d at 29°C. kismet EC knockdown had no 
impact on Delta+ cell number (RED) when compared to control (GFP, GREEN; DAPI, BLUE). (J, 
K) NREts driven expression of GFP alone (J) or with a kis RNAi (BL36597) (K) in the EB for 10 
days at 29°C. kismet EB knockdown had no impact on Delta+ cells number (RED) when compared 
to control (GFP, GREEN; DAPI, BLUE). (L, M) prosts driven expression of GFP alone (L) or with 
a kis RNAi (BL36597) (M) in the EE cells for 10 days at 29°C. kismet EE knockdown had no impact 
on Delta+ cells number (RED) when compared to control (GFP, GREEN; DAPI, BLUE). Scale 
bars=20 µm. 
 
Figure S3. kismet mutant ISC are able to differentiate in response to Notch signaling 
activation, related to Figure 3. 
(A, B) Notch extra cellular domain (RED) was expressed in most diploid cells in both wild-type 
control (A), and kis10D26 mutant (B), clones at 9 days AHS (GFP, GREEN; DAPI, BLUE). (C-D’) 
Notch transcriptional reporter activity (NRE-LacZ) was detected in both wild-type control clones 
(C), and kis10D26 clones (D), at 9 days AHS (clones outlined in WHITE, GFP, GREEN in C, D; 
DAPI, BLUE; ßGAL, RED; Delta, GREEN in C’, D’). (E, F) Quantification of the average number 
of (NRE+, Delta+) and (NRE-, Delta+) cells per clone (E) and the relative percent of each cell type 
(F) from (C-D’). (G) Experimental set-up: to test the effect of Notch activation on the extra ISCs 
accumulating in kis10D26 mutant conditions, wild-type or mutant clones were induced by heat-shock. 
Flies were maintained for 10 days at 18°C however expression of UAS-GFP and UAS-NAct (an 
activated form of Notch) was blocked using GAL80ts, active at 18°C. Flies were either maintained 
at 18°C or switched to a restrictive temperature of 29°C for 3 days to inactivate GAL80ts thereby 
allowing GAL4-driven UAS-GFP and UAS-NAct expression. (H, I) Guts 13 days AHS at 18°C 
containing unmarked wild-type (H), or kis10D26 mutant clones (I). Note that the kis10D26 mutant clones 
could be detected through ISC accumulation marked by Delta (RED; DAPI, BLUE; No GFP and no 
NAct expression). (J, K) ISCs were lost upon UAS-NAct in wild-type (J), or kis10D26 mutant clones (K), 
maintained for 10 days at 18°C AHS before transfer for 3 days at 29°C (GFP, GREEN, DAPI in 
BLUE and Delta in RED). Most cells in clones had large nuclei, characteristic of ECs. (L) 
Quantification of total cells per clone, ISCs per clone and ECs per clone after a 3 days switch to 
29°C from (J, K). Results were compared using a two-tailed Mann-Whitney statistical test. Mean 
values in RED; error bars=SEM. Scale bars=20 µm. 
 
Figure S4. Additional pathways participate to ISC proliferation induced by kismet loss, related 
to Figure 3. 
(A-B’) Wild-type control (A, A’), and kis10D26 mutant clones (B, B’), 9 days AHS MARCM clones. 
As reported in (Biteau et al., 2008) JNK signaling activity, detected by Puc-LacZ (RED in A-B’) 
was detected in wild-type ECs of 15 days old flies but absent in ISCs. While Puc-LacZ was not 
changed in kis10D26 mutant ECs, it was markedly increased in ISCs (clone outlined in WHITE in A’, 
B’; GFP, GREEN; Delta, BLUE; arrowheads point toward ISC). (C-D’) Wild-type control (C, C’), 
and kis10D26 mutant clones (D, D’), 9 days AHS MARCM clones. JAK/STAT signaling, detected by 
10X-STATGFP (GREEN in C-D’) was markedly increased in kis10D26 mutant clones (clone outlined 
in WHITE in C’, D’; RFP, RED; DAPI, BLUE). (E) Quantification of the number of cells per clone, 
the number of Delta+ cells per clone, and the % of Delta+ cells per clone from 12 day old wild-type 
control, kis10D26 mutant clones, expressing a dominant form of JNK pathway component basket 
(bskDN), an RNAi construct targeting the JAK/STAT receptor coding gene dome (dome), expressing 
a dominant negative form of Insulin receptor (InRDN) or an RNAi construct targeting the Hippo 
pathway component Yki (yki RNAi construct). (F-M’) Wild-type control (F, F’, G, G’, L, L’), and 
kis10D26 mutant clones (G G’, J, J’, M, M’), 3 days AHS MARCM clones. Ligands of JAK/STAT 
Upd (expressed in ISC and EC) and Upd3 (expressed in the EC) respectively detected using Upd-
LacZ (RED in F-G’, arrowheads point toward ISC) and Upd3-LacZ (RED in I-J’, arrowheads point 
toward EC) and JNK activity reporter Puc-lacZ (RED in L-M’, arrowheads points toward ISC) were 
not increasingly expressed in kismet mutants at 3 days AHS (clone outlined in WHITE in F’, G’, I’, 
M’; GFRP, GREEN; DAPI, BLUE). (H, K, N) Quantification of the proportion of ISC expressing 
Upd-LacZ (H), EC expressing Upd3-lacZ (K) and ISC expressing Puc-LacZ (N) in clones from (F-
M’).  Results compared with two-tailed Mann-Whitney statistical test in (E) and a Chi2 test in (H, 
K and N). Mean values in RED, error bars= SEM. Scale bars=20 µm. 
 
Figure S5. Kismet distribution on lineage specific genes, related to Figure 4. 
(A-A”) Super-resolution image of Kismet distribution (Kismet-FLAP tagged kislocus marked by 
GFP, GREEN) in the nuclei of enterocytes. Kismet was found to be enriched in regions 
generally lacking the H3K27me3 repressive mark (RED). Scale bar = 5µm. (B-H) Wild-type 
RNAseq, as well as Dam-Kis, Dam-RNA Pol II, Dam-Pc, Dam-Brm, Dam-HP1, DamH1 ISC 
binding profiles and peaks alignments over: (B) the genomic region of the gene esg, expressed 
in the ISCs (having significant RNA Pol II occupancy); (C, D) the genomic region of genes not 
expressed in the ISCs with low level of Dam-RNA Pol II recruitment (RNA Pol II mean 
occupancy not significant) though bound by Kismet such as pros (C) and pdm1 (D); (E) the 
genomic region of genes ytr and eIF6 not bound by Kismet but expressed in ISCs; (F, G) the 
genomic region of genes not expressed in ISCs amon (EE specific), and pvf3 (EE enriched) 
(G); (H) the chromosome 3L pericentromeric region at the euchromatin / heterochromatin 
boundary. 
 
Figure S6. trr but not ash1, trx, brm and set1 chromatin modifiers regulates ISC proliferation 
similarly to kismet, related to Figure 5. 
(A-B’) Histone H3K27me3 marks (RED) were broadly distributed in cells of wild-type control (A, 
A’) and kis10D26 mutant clones (B, B’) 9 days AHS; (clones outlined in WHITE; GFP, GREEN; 
DAPI, BLUE). (C-G) Wild-type clones (C), and those expressing an ash1 RNAi construct (D), trxE2 
mutant clones (E), or expressing a brm RNAi construct (F) or a set1 RNAi construct (G) at 9 days 
AHS (clones outlined in WHITE; GFP, GREEN; DAPI, BLUE; Delta, RED). No obvious kismet-
like ISC accumulation phenotype was detected. (H, I) Quantification of cells per clone (H), and the 
Delta+ cells per clone (I) from (C, D, F). (J) Quantification of cells per clone and the Delta+ cells 
per clone from (K-L’). (K-L’) Wild-type (K, K’), and trrB mutant clones (L, L’), 9 days AHS 
MARCM clones; (Clones outlined in WHITE, in K’, L’; GFP, GREEN; DAPI, BLUE; Delta, RED). 
(M-N’) Histone H3K27ac marks (RED) were broadly distributed in cells of wild-type control (M, 
M’) and kis10D26 mutant clones (N, N’) 9 days AHS; (clones outlined in WHITE; GFP, GREEN; 
DAPI, BLUE). (O-P’, R-S’) ISC-specific expression of GFP (O, O’), Cbl RNAi (P, P’), kis RNAi 
(BL34908) (R, R’) and trr RNAi (S, S’) for 3 days at 29°C. Arrows highlight ISC cells. (Q, T) Total 
EGFR fluorescence intensity in GFP+ ISCs (Q), and of the mean EGFR fluorescence intensity per 
GFP+ ISC (T) in control guts and knock-downs of Cbl, kismet and trr from (O-P’, R-S’). Results 
were compared using a two-tailed Mann-Whitney statistical test. Mean values in red; error bars= 
SEM. Scale bars=20 µm. 
 
Figure S7. Effects on Histone modifications, Kismet, and Trr COMPASS-like proteins in 
mutant contexts, related to Figure 7. 
(A-B’) Wild-type clones (A, A’), and expressing RNAi construct against trr (B, B’) at 9 days AHS 
(clones outlined in WHITE; GFP, GREEN; DAPI, BLUE; dpERK, RED) showed an increase in 
EGFR pathway activity upon knock-down of trr. (C-F) A control wild-type clone (C), a kis10D26 
mutant clone (D), a clone expressing trr RNAi (E), a kis10D26 mutant clone expressing trr RNAi (F) 
at 10 days AHS (GFP, GREEN; DAPI, BLUE; Delta, RED). (G) Quantification of clone size and 
number of Delta+ cells per clone from (C-F). (H-I’) Kismet protein (RED) in wild-type control 
clones (H, H’), and trr RNAi construct expressing clones (I, I') (clones outlined in WHITE; GFP, 
GREEN; DAPI, BLUE). (J-K’) Trr protein (RED) in wild-type control (J, J’) and kis10D26 mutant 
clones (K, K’), 9 days AHS (clones are outlined in WHITE; GFP, GREEN; DAPI, BLUE). No 
changes were found in Kismet or Trr intensity from wild-type to mutant contexts. (L-O’) Histone 
H3K4me1 marks (RED) were broadly distributed in wild-type control clones (L, L’), but greatly 
reduced in both trr RNAi (M, M’) and lpt RNAi construct expressing clones (N, N’). In contrast, 
kis10D26 mutant clones (O, O’) showed no obvious reduction in Histone H3K4me1 levels (9 days 
AHS; clones are outlined in WHITE; GFP, GREEN; DAPI, BLUE). Results were compared using 
a two-tailed Mann-Whitney statistical test. Mean values in RED; error bars= SEM. Scale bars=20 
µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
